Cardiac Metastases in Patients with Neuroendocrine Tumours: Clinical Features, Therapy Outcomes, and Prognostic Implications

202020 citationsJournal Article

Authors

Man Liu · The First Affiliated Hospital, Sun Yat-sen University

Eleni Armeni · Royal Free London NHS Foundation Trust

Shaunak Navalkissoor · The Royal Free Hospital

Joseph Davar · The Royal Free Hospital

Luke Sullivan · University College London

Charlotte Leigh · University College London

Luke Furtado O’Mahony

Abstract

Clinical features of NET CM ranged from asymptomatic patients to heart failure. Concomitant bone or pancreatic metastases and NT pro-BNP levels >2 ULN predicted shorter survival time. PRRT serves as a feasible therapy with promising survival benefits; however, more data are needed.

Topics & Keywords

Neuroendocrine Tumor Research Advances Peptidase Inhibition and Analysis Cardiac tumors and thrombi

Publication Details

Published in: Neuroendocrinology

Volume 111, Issue 10, pp. 907-924

DOI: 10.1159/000510444

Field-Weighted Citation Impact: 1.30

Command Palette

Cardiac Metastases in Patients with Neuroendocrine Tumours: Clinical Features, Therapy Outcomes, and Prognostic Implications

Authors

Abstract

Topics & Keywords

Publication Details